This brand name is authorized in United States
The drug DAYBUE contains one active pharmaceutical ingredient (API):
|
1
Trofinetide
UNII Z2ME8F52QL - TROFINETIDE
|
|
Trofinetide is indicated for the treatment of Rett syndrome. The mechanism by which trofinetide exerts its therapeutic effects is unknown. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| DAYBUE Oral solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: US | FDA, National Drug Code | Identifier(s): 63090-660 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
